SCHEMBL6444368

SCHEMBL6444368

CC(=O)NC(C)Cc1nc2cc(C(F)(F)F)c(Cl)cc2n1-c1c[c]ccc1

nearest known ligand 0.37

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ACACB O00763 16/20 0.37
POLB P06746 1/20 0.33
NR1H2 P55055 1/20 0.32
NR1H3 Q13133 1/20 0.32
IRAK4 Q9NWZ3 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7097335 0.81 NR1H2 (0.37) NR1H2NR1H3
SCHEMBL7101227 0.79 NOTUM (0.31)
SCHEMBL7101205 0.78 TDP1 (0.31) NR1H2NR1H3
SCHEMBL7104436 0.75 AR (0.35) IRAK4
SCHEMBL7102507 0.74
SCHEMBL7102225 0.74
SCHEMBL6425191 0.72 ALDH1A1 (0.36)
SCHEMBL7100147 0.71 HSD11B1 (0.34)
SCHEMBL28749688 0.70 AOC3 (0.39) NR1H2NR1H3
SCHEMBL6017895 0.69 DHFR (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1499305-A2 USE OF EP4 RECEPTOR LIGANDS IN THE TREATMENT OF IL-6 INVOLVED DISEASES Pfizer Japan Inc. (JP) 2005-01-26 EP disclosed
WO-2003086371-A2 USE OF EP4 RECEPTOR LIGANDS IN THE TREATMENT OF IL-6 INVOLVED DISEASES PFIZER JAPAN INC. (JP) 2003-10-23 WO disclosed